REG - AVANGARDCO INV - 3rd Quarter Results <Origin Href="QuoteRef">AVGRq.L</Origin>

Avangardco Investments PublicAnnouncement

30/11/2015 07:11

RNS Number : 2825H
AvangardCo Investments Public Ltd
30 November 2015
30 November 2015 
AVANGARDCO INVESTMENTS PUBLIC LIMITED
FINANCIAL RESULTS FOR Q3 AND 9M 2015
yiv, Ukraine - AVANGARDCO INVESTMENTS PUBLIC LIMITED (LSE: AVGR) (the "Company" or "AVANGARDCO IPL"), the largest producer of shell eggs and egg products in Ukraine and number one producer in Europe, announces its financial results for the third quarter and nine months ended 30 September 2015.
Financial Highlights for Q3 2015
 Consolidated revenue of US$55.1mln, a decrease of 43% YoY (Q3 2014: US$97.0 mln).
 Gross profit of US$5.4 mln, a decline of 77% YoY (Q3 2014: US$23.7 mln).
 EBITDA increased by 83% YoY to US$13.2 mln (Q3 2014: US$7.2 mln).
 Net profit of US$1.1 mln (Q3 2014: net loss of US$47.6 mln).
Financial Highlights for 9M 2015:
 Consolidated revenue amounted to US$176.5 mln, a decrease of 50% YoY (9M 2014: US$354.7 mln). 
 Export sales revenue amounted to US$71.2 mln or 40% of the Company's consolidated revenue (9M 2014: US$134.8 mln or 38% of the consolidated revenue).
 Gross profit of US$12.9 mln, a decline of 87% YoY (9M 2014: US$102.1 mln).
 Operating loss amounted to US$102.1 mln (9M 2014:operating profit of US$67.6 mln).
 EBITDA loss of US$84.3 mln (9M 2014: EBITDA US$108.6 mln).
 Net loss amounted to US$150.5 mln (9M 2014: net loss of US$5.7 mln). 
Operational Highlights for 9M 2015: 
 Production of shell eggs totalled 2,735 mln units, a decline of 47% YoY (9M 2014: 5,114 mln units).
 Sales of shell eggs to external clients amounted to 2,308 mln units, down by 34% YoY (9M 2014: 3,499 mln units).
 Export of shell eggs amounted to 326 mln units, a decline of 29% YoY (9M 2014: 462 mln units).
 The average sales price of shell eggs was UAH 1.13 per unit, excluding VAT, up by 59% YoY (9M 2014: UAH 0.71 per unit, excluding VAT).
 The production of dry egg products amounted to 6,567 tonnes, a decline of 63% YoY (9M 2014: 17,739 tonnes).
 Sales of dry egg products totalled 8,695 tonnes, down by 45% YoY (9M 2014: 15,882 tonnes).
 Export of dry egg products amounted to 6,575 tonnes, a decline of 50% YoY (9M 2014: 13,046 tonnes)
 As at 30 September 2015, the total poultry flock amounted to 19.0 mln hens, a decrease of 27% YoY (30 September 2014: 25.9 mln). 
 As at 30 September 2015, the number of laying hens amounted to 13.7 mln, down by 26% YoY (30 September 2014: 18.5 mln). 
Post Period Highlight:
 On 28 October 2015, AVANGARDCO IPL completed a successful restructuring deal and extended the maturity of the Eurobonds from 29 October 2015 to 29 October 2018.
IrinaMarchenko, ChiefExecutiveOfficerofAVANGARDCOIPL, commented:
"In Q3 and 9M 2015, we have made a number of important steps towards our strategic goals, for example, we have started to gradually increase our poultry flock at the farms outside the affected regions, with a target to grow production of shell eggs and dry egg products for export and sales through supermarket chains in the nearest future. We continued to develop exports to the EU in line with of our strategy of export expansion, where we have more than doubled exports of dry egg products in Q3 compared to Q2 2015. To date, we are exporting egg products to Denmark, the United Kingdom, Latvia and Italy. The increase in the share of sales to the EU will enable us to diversify exports and mitigate the impact following volatility in the Middle East. Our entry into Israel in September 2015 - including some profitable long term shell egg contracts - along with export permission rights and delivery to Qatar for the first time in October 2015 were also key milestones which position the Company well for future growth.
In addition, the most important recent development for us was the successful restructuring of our Eurobonds, which became possible with the support of our bondholders. We hope that this will help to improve current liquidity and release funds to finance operations and recapture the Company's market position. I would like to thank our bondholders for their support."
###
The management will host a conference call and webcast for investors and analysts on Monday, 30 November 2015 at 09.00 am US Eastern time, 14.00 pm UK time, 16.00 pm Kiev time and 17.00 pm Moscow time.
Name:
AVANGARDCO Q3 2015 FINANCIAL RESULTS
ID:  
ID 88644796
UK Free call
0800 073 1340
Russia Free call
88007756818
USA
1866 434 1089
UK Standard International
+44 (0) 1452 569 393
A live webcast of the presentation will be available at: 
https://webconnect.webex.com/webconnect/onstage/g.php?MTID=e020df2b3b54ad3f50ccc18d42e296da1
Please register approximately 15 minutes prior to the start of the call.
Financial results for the nine months ended 30 September 2015 are available on the Company's website at: http://avangard.co.ua/eng/for-investors/financial-overview/financial-reports/interim-reports/
###
Financial results overview
Units
Q3 2015*
Q3 2014*
Change, %
9M 2015
9M 2014
Change, %
Consolidated Revenue
US$ '000
55,152
97,023
(43%)
176,477
354,693
(50%)
Gross Profit/(Loss)
US$ '000
5,391
23,676
(77%)
12,920
102,085
(87%)
Gross Profit Margin
%
10%
24%
-
7%
29%
-
EBITDA
US$ '000
13,191
7,198
83%
(84,303)
108,628
-
EBITDA Margin
%
24%
7%
-
-
31%
-
Operating Profit/(Loss)
US$ '000
7,674
(19,845)
-
(102,069)
67,638
-
Operating Margin
%
14%
-
-
-
19%
-
Net Profit/(Loss)
US$ '000
1,080
(47,577)
-
(150,486)
(5,747)
-
Net Profit Margin
%
2%
-
-
-
-
-
*recalculated at the average UAH/USD exchange rate for the third quarter of 2014 and 2015
The exchange rates used for the preparation of consolidated financial statements:
Q3 2015:
Currency
30September2015
Weighted average for Q3 2015
30 September2014
Weighted average for Q3 2014
US dollar to Ukrainian Hryvnia
21.528
21.722
12.949
12.577
InQ3 2015, theCompany'sconsolidatedrevenuedecreasedby43% YoY toUS$55.1 mln (Q3 2014: US$97.0mln)as a result of lower sales of shell eggs and dry egg products alongside the decreased average sales price in dollar terms for both products. 
InQ3 2015, gross profit declined by 77% YoY and amounted to US$5.4 mln (Q3 2014: US$23.7 mln)due to reduced revenue andincreased cost per unit of output. Gross profit margin was 10%.
In Q3 2015, EBITDA increased by 83% YoY to US$13.2 mln(Q3 2014: US$7.2 mln which included a one-off impairment charge following the closure of the production operations in Crimea and Eastern Ukraine).
In Q3 2015, the Company reported net profit of US$1.1 mln (Q3 2014: net loss of US$47.6 mln) driven by increased operating income and lower FX losses.
9M 2015:
Currency
30September2015
Weighted average for the 9 months ended 
30 September 2015
30 September2014
Weighted average for the 9 months ended 30 September 2014
US dollar to Ukrainian Hryvnia
21.528
21.485
12.949
11.059
In 9M 2015, the Company's consolidated revenue decreased by 50% YoY to US$176.5 mln (9M 2014: US$354.7 mln). This was attributed to two main factors: lower sales of shell eggs and dry egg products which were down by 34% and 45% respectively and the devaluation of the Ukrainian hryvnia against the US dollar.
In 9M 2015, the Company's export revenues decreased by 47% YoY to US$71.2 mln (9M 2014: US$134.8 mln) as a result of lower export sales of shell eggs and dry egg products. Despite this, the share of exports in the consolidated revenue grew to 40% (9M 2014: 38%).
In the reporting period, the cost of sales in dollar terms fell by 36% YoY to US$166.1 mln (9M 2014: US$261.1 mln) due to the devaluation of the Ukrainian Hryvnia against the US dollar. The cost of sales in Hryvnia terms increased as the price of over 70% of the components (grain, veterinary medicines, and packaging materials) is linked to other major currencies. The cost of services provided by third parties (utilities, warehouse lease, veterinary services, and transport costs) increased due to the devaluation of the Ukrainian Hryvnia against the US dollar and the tariff revision.
As a result of the decrease in the consolidated revenue and increase in the cost of sales per unit, the Company's gross profit was down by 87% to US$12.9 mln (9M 2014: US $102.1 mln). Gross profit margin decreased to 7% (9M 2014: 29%).
In 9M 2015, the loss from operating activities amounted to US$102.1 mln (9M 2014: operating profit of $67.6 mln). This loss is largely attributed to a write down in H1 2015 of sub-standard raw material inventories and inventories of finished goods with expired shelf life, provisions for doubtful debts and funds deposited with the Financial Initiative bank due to its insolvency.
This led to EBITDA loss of US$84.3 mln (9M 2014: EBITDA US$108.6 mln). 
In 9M 2015, the Company reported a net loss of US$150.5 mln (9M 2014: net loss of US$5.7 mln) which includes FX losses of US$33.5 mln.
Cash flow and debt structure:
As at 30 September 2015, net cash flow from operating activities decreased to US$6.8 mln (30 September 2014: US$41.2 mln) due to the reduced operating profit and increased inventories. 
Net cash used in investing activities amounted to US$30.4 mln for maintenance capex (30 September 2014: US$54.9 mln).
Net cash used in financing activities was US$6.9 mln (30 September 2014: net cash received from financing activities US$21.3 mln).
As at 30 September 2015, net cash outflow amounted to US$30.5 mln (30 September 2014: net cash inflow US$7.6mln). Cash and cash equivalents decreased to US$42.3 mln (30 September 2014: US$157.6 mln) as cash outflow from financing and investing activities exceeded the funds inflow from operating activities. The written off funds deposited with the Financial Initiative bank also had an impact.
As at 30 September 2015, the Company's total debt amounted to US$339.9 mln (31 December 2014: US$343.8 mln). Net debt amounted to US$297.6 mln (31 December 2014: US$225.9mln). 
Restructuring of Eurobonds:
On 28 October 2015 AVANGARDCO IPL completed the restructuring deal and extended the maturity of the Eurobonds from 29 October 2015 to 29 October 2018. In addition to other amendments, the following changes on the coupon payment have been agreed:
 The 5% coupon will be payable on 29 October 2015 (representing the semi-annual payment of the existing 10% coupon), with 2% to be paid in cash as a regular coupon paymentand 3% to be paid as payment in kind ("PIK").
 The 10% coupon will be payable semi-annually in arrears on 29 April and 29 October of each year, commencing 29 April 2016, but subject to the following PIKand cash payment provisions:
Interest payment date
PIK Interest %
Cash Interest %
29.04.16
75
25
29.10.16
75
25
29.04.17
50
50
29.10.17
50
50
29.04.18
25
75
29.10.18
0
100
The full information on the restructuring deal is available at: http://avangard.co.ua/eng/
Segment review
Shell Eggs Segment
Units
As at 30.09.2015
As at 30.09.2014
Change
Total Poultry Flock
Heads (mln)
19.0
25.9
(27%)
Laying Hens
Heads (mln)
13.7
18.5
(26%)
As at 30 September 2015, the total poultry flock was down by 27% YoY to 19.0 million heads (30 September 2014: 25.9 million heads) and the number of laying hens decreased by 26% YoY to 13.7 million heads (30 September 2014: 18.5 million heads). The decrease in poultry flock size was due to the full suspension of laying farms in Eastern Ukraine close to the conflict zone[1]. This also coincided with lower domestic demand for shell eggs resulting from the reduction in consumer's purchasing power and the loss of sales markets in Crimea and Eastern Ukraine.
Units
Q3 2015
Q3 2014
Change
9M 2015
9M 2014
Change
Total Production
Units (mln)
843
1,434
(41%)
2,735
5,114
(47%)
Total Sales to Third Parties
Units (mln)
608
1,096
(45%)
2,308
3,499
(34%)
Export
Units (mln)
119
155
(23%)
326
462
(29%)
Average Sales Price
UAH (excl. VAT)
1.28
0.80
60%
1.13
0.71
59%
The production volume of shell eggs decreased by 41% YoY to 843 million units in Q3 2015 (Q3 2014: 1,434 million units) and by 47% YoY to 2,735 million units in 9M 2015(9M 2014: 5,114 million units) due to the decreased number of laying hens.
Accordingly, in Q3 2015, sales of shell eggs to external customers decreased by 45% YoY to 608 million units (Q3 2014: 1,096 million units) and by 34% YoY to 2,308 million units in 9M 2015 (9M 2014: 3,499 million units). 
In 9M 2015, the share of shell egg sales through retail chains increased to 42% of total external sales (9M 2014: 36%), whilst to less marginal wholesale channels it decreased to 44% (9M 2014: 51%).
In Q3 2015, exports of shell eggs was down by 23% YoY to 119 million units (Q3 2014: 155 million units) and by 29% YoY to 326 million units in 9M 2015 (9M 2014: 462 million units). This was mainly due to no exports of shell eggs to Liberia as a result of the increased competition between egg producers for this market, as well as the ongoing disruptions in the Company's key export markets in the Middle East. Given the volatile situation in the Middle East, the Company has been looking for new export markets. In September 2015, the Company started to export its shell eggs to Israel after closing several profitable long-term contracts. In October 2015, the Company obtained export permission rights and made its first shipment of shell eggs to Qatar. The share of exports volume in 9M 2015 slightly increased to 14% compared to 13% in 9M 2014. In 9M 2015, the Company exported shell eggs to Iraq, UAE, Moldova and Israel.

In Q3 2015, the average sales price of shell eggs increased by 60% YoY to 1.28 UAH per unit, excluding VAT (Q3 2014: 0.80 UAH per unit, excluding VAT) and by 59% YoY to 1.13 UAH per unit, excluding VAT in 9M 2015 (9M 2014: 0.71 UAH per unit, excluding VAT) due to inflation and seasonal price growth. In 9M 2015 the average sales price in dollar terms decreased by 17% YoY and amounted to US$0.053 per unit, which is slightly above the cost of sales (9M 2014: US$0.064 per unit).
In 9M 2015, the segment's revenue decreased by 46% YoY to US$121.4 mln (9M 2014: US$226.0 mln), resulting from the decreased sales of shell eggs and average sales price in dollar terms. The segment's net loss amounted to US$25.5 mln (9M 2014: net profit of US$ 40.7 mln). 
Dry Egg Products Segment
Units
Q3 2015
Q3 2014
Change
9M 2015
9M 2014
Change
Dry egg products production
Tonnes
3,005
3,728
(19%) 
6,567
17,739
(63%)
Sales volume
Tonnes
3,004
3,496
(14%)
8,695
15,882
(45%) 
Export
Tonnes
2,526
2,972
(15%)
6,575
13,046
(50%)
Average Sales Price
US$/Kg
5.89
6.61
(11%)
5.57
6.51
(14%)
Units
Q3 2015
Q2 2015
Change
Dry egg products production
Tonnes
3,005
2,412
25% 
Sales volume
Tonnes
3,004
2,440
23%
Export
Tonnes
2,526
1,928
31%
Average Sales Price
US$/Kg
5.89
5.67
4%
In Q3 2015, the production volume of dry egg products decreased by 19% YoY to 3,005 tonnes (Q3 2014: 3,758 tonnes), whilst in 9M 2015 it was down by 63% YoY to 6,567 tonnes (9M 2014: 17,739 tonnes). As per its stated strategy to balance sales mix and manage inventories, the Company has started to plan its production based on existing orders to avoid an accumulation of dry egg product inventories.
In Q3 2015, the volume of sales of dry egg products decreased by 14% YoY to 3,004 tonnes (Q3 2014: 3,496 tonnes) and by 45% YoY to 8,695 tonnes in 9M 2015 (9M 2014: 15,882 tonnes). 
In Q3 2015, the export of dry egg products declined by 15% YoY to 2,526 tonnes (Q3 2014: 2,972 tonnes) and by 50% YoY to 6,575 tonnes in 9M 2015, or 76% from the total sales (9M 2014: 13,046 tonnes, or 82% from the total sales). The main importers of the Company's dry egg products were Asia and Oceania, the EU and MENA. As per the stated strategy, in Q3 2015, the Company continued to expand its exports to the new markets, including Iran and Latvia. In Q4 2015, the Company entered the Italian market. 
However, in Q3 2015 compared to Q2 2015, the Company saw an increase in both production by 25% QoQ and sales by 23% QoQ thanks to the growth in export demand. During the same period, the export of dry egg products was up by 31% QoQ driven by the twofold increase in sales to the EU and moderate growth in sales to Asia. Unfortunately, exports to the Middle East declined as this continued to depend on the volatile situation in the region.
In Q3 2015, the average sales price of dry egg products decreased by 11% YoY to US$5.89/kg (Q3 2014: US$6.61/kg) and by 14% YoY to US$5.57/kg in 9M 2015 (9M 2014: US$6.51kg) as a result of an increase in the share of sales of less marginal egg products and domestic sales. 
In 9M 2015, as a result of the decreased sales and average sales price of dry egg products, the segment's revenue was down by 53% YoY to US$48.4 mln (9M 2014: US$103.3 mln). The segment's net loss amounted to US$29.4 mln (9M 2014: net profit of US$30.5 mln) and was affected by reduced sales volumes and lower average sales price.
- Ends -
For investor's inquiries:
Valeriya Myagkohod 
AVANGARDCO IPL 
Investor Relations Manager 
phone: +38 044 393 40 50 
mob.: +38 067 223 46 88 
e-mail: ir@avangardco.ua
FTI Consulting London
Elena Kalinskaya / Nicola Krafft
phone: +44 (0) 20 3727 1000
e-mail:avangard@fticonsulting.com
# # #
Information for editors
AVANGARDCO IPL is one of the largest agro-industrial companies in Ukraine, specialising in the production of shell eggs and dry egg products. As at 30 September 2015, the Company holds a 36% share of the industrial shell eggs market and a 79% share of the dry eggs products market in Ukraine. The Company's laying hens flock is one of the largest globally. 
AVANGARDCO IPL has a vertically integrated production cycle. The Company's facilities are located in 14 regions of Ukraine and the Autonomous Republic of Crimea. The Company has 19 farms for laying hens, 3 second order breeder farms, 10 farms for rearing young laying hens, 6 feed mills, 3 long-term storage facilities and the Imperovo Foods egg processing plant, which is one of the most technologically-advanced facilities for processing eggs in Europe. 
The Company exports its products to 42 countries, with its primary export markets in the Middle East, Africa, Asia, the CIS and EU. 
The Company's shares, in the form of Global Depositary Receipts, have been trading on the London Stock Exchange since May 2010. The Eurobond issue for approximately US$200 mln with a maturity on 29 October 2018 was included in the official list of the UK Listing Authority (UKLA) and admitted to trading on a regulated market of the London Stock Exchange on 1 November 2010.
# # #
Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of AVANGARDCO IPL. You can identify forward looking statements by terms such as "expect," "believe," "anticipate," "estimate," "intend," "will," "could," "may" or "might", the negative of such terms or other similar expressions. We wish to caution you that these statements are only predictions and that actual events or results may differ materially. We do not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Many factors could cause the actual results to differ materially from those contained in our projections or forward-looking statements, including, among others, general economic conditions, our competitive environment, risks associated with operating in the Company's geographical locations, rapid technological and market changes in our industry, as well as many other risks specifically related to AVANGARDCO IPL and its operations.
Condensed consolidated statement of financial position
AS AT 30 SEPTEMBER 2015
(in USD thousand, unless otherwise stated)
30 September 2015
31 December 2014
ASSETS
Property, plant and equipment
439,091 
579,922 
Non-current biological assets
23,771 
21,637 
Deferred tax assets
4,334 
2,489 
Held to maturity investments
10,036 
17,959 
Other non-current assets
20 
28 
Total non-current assets
477,252 
622,035 
Inventories
66,248 
115,896 
Current biological assets
14,948 
28,228 
Trade accounts receivable, net
61,054 
79,221 
Prepaid income tax
71 
48 
Prepayments and other current assets, net
12,500 
29,094 
Taxes recoverable and prepaid
10,589 
45,949 
Cash and cash equivalents
42,315 
117,856 
Total current assets
207,725 
416, 292 
TOTAL ASSETS 
684,977 
1,038,327 
EQUITY
Share capital
836 
836 
Share premium
201,164 
201,164 
Reserve capital
115 858 
115,858 
Retained earnings
931,033 
1,077,158 
Effect of translation into presentation currency
(947,906)
(776,404)
Equity attributable to owners of the Company
300,985 
618,612 
Non-controlling interests
(7,000)
27,276 
Total equity 
293,985 
645 888 
LIABILITIES
Long-term loans
70,529 
79 844 
Deferred tax liabilities
14 
26 
Deferred income
1,567 
2,245 
Long-term finance lease
38 
63 
Total non-current liabilities
72,148 
82,178 
Short-term bond liabilities
199,864 
198,635 
Current portion of non-current liabilities
19,597 
15,368 
Short-term loans
50,000 
50,000 
Trade payables
3,855 
6,907 
Other accounts payable
45,528 
39,351 
Total current liabilities
318,844 
310,261 
TOTAL LIABILITIES
390,992 
392,439 
TOTAL EQUITY AND LIABILITIES
684,977 
1,038,327 
Condensed consolidated statement of profit and loss and other comprehensive income
FORTHE 9 Months ENDED 30SEPTEMBER 2015
(in USD thousand, unless otherwise stated)
9 months ended
30 September 2015
30 September 2014
Revenue
176,477 
354,693 
Profit from revaluation of biological assets at fair value
2,590 
8,534 
Cost of sales
(166,47)
(261,142)
GROSS PROFIT
12,920 
102,085 
General administrative expenses
(5,453)
(9,160)
Distribution expenses
(8,893)
(15,018)
Income from government grants and incentives
85 
110 
Impairment of non current assets
- 
(25,751)
Income from special VAT treatment
12,735 
33,153 
Other operating expenses
(113,463)
(17,781)
(LOSS)/PROFIT FROM OPERATING ACTIVITIES
(102,069)
67,638 
Finance income
3,097 
143 
Finance costs
(20,520)
(23,778)
Losses on exchange
(33,496)
(49,461)
LOSS BEFORE TAX
(152,988)
(5,458)
Income tax credit/(expence)
2,502 
(289)
LOSS FOR THE PERIOD
(150,486)
(5,747)
OTHER COMPREHENSIVE INCOME
Items that are or may be reclassified subsequently to profit or loss
Effect from translation into presentation currency
(205,285)
(550,712)
Effect from changes in ownership
- 
1,714 
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD
(355,771)
(554,745)
LOSS ATTRIBUTABLE TO
Owners of the Company
(146,125)
(5,412)
Non-controlling interests
(4,361)
(335)
(150,486)
(5,747)
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO
Owners of the Company
(317,627)
(540,442)
Non-controlling interests
(38,144)
(40,920)
(355,771)
(581 362)
Loss per share, USD (basic and diluted)
(23)
(1)
Condensed consolidated statement of cash flows
FORTHE 9 Months ENDED 30SEPTEMBER 2015
(in USD thousand, unless otherwise stated)
9 months ended
30 September 2015
30 September 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Loss before income tax
(152,988)
(5,458)
Adjustments for:
Depreciation of property, plant and equipment
17,766 
15,239 
Change in allowance for irrecoverable amounts 
40,699 
10,224 
Other provisions 
- 
(608)
Loss/(profit) on disposal of current assets
130 
(50)
Loss on disposal of property, plant and equipment
66 
2,235 
Impairment of current assets
37,560 
10,159 
Effect of fair value adjustments on biological assets
(2,590)
(8,534)
Gains realised from accounts payable written-off
(91)
(4,088)
Amortization of deferred income on government grants
(85)
(110)
Discount bonds amortization
1,229 
1,106 
Impairment of non current assets
- 
25,751 
Impairement of funds
28,863 
- 
Discount on VAT government bonds amortization
(1,528)
- 
Interest income
(1,569)
(143)
Interest payable on loans
19,269 
21,856 
Losses on exchange
41,636 
41,252 
Operating profit before working capital changes
28,367 
108,831 
Increase in trade receivables
(26,421)
(53,260)
Decrease in prepayments and other current assets
2,558 
49 
Decrease/(increase) in taxes recoverable and prepaid
27,766 
(23,870)
Increase in inventories
(18,933)
(10,304)
Decrease in deferred income
- 
(155)
Decrease in other non-current assets
- 
343 
Decrease in trade payables
(1,115)
(955)
Decrease in biological assets
316 
28,080 
Decrease in finance leases
(9)
(1,145)
(Decrease)/increase in other accounts payable
(2,223)
538 
Cash generated from operations
10,306 
48,151 
Interest paid
(3,439)
(6,941)
Income tax paid
(54)
(41)
Net cash generated from operating activities
6,813 
41,169 
CASH FLOWS FROM INVESTING ACTIVITIES
Payments and receipts - property, plant and equipment
(32,542)
(55,011)
Interest received
2,134 
143 
Net cash used in investing activities
(30,408)
(54,868)
Condensed consolidated statement of cash flows (cont.)
FOR THE9 Months ENDED 30SEPTEMBER 2015
(in USD thousand, unless otherwise stated)
9 months ended
30 September 2015
30 September 2014
CASH FLOWS FROM FINANCING ACTIVITIES
New loans received
12,452 
90,630 
Repayment of loans
(9,382)
(59,361)
Interest paid for bonds issued
(10,000)
(10,000)
Net cash (used in)/generated from financing activities
(6,930)
21,269 
Net (decrease)/increase in cash
(30,526)
7,571 
Cash and cash equivalents at 1 January
117,856 
156,804 
Impairement of funds
(28,701)
- 
Effect from translation into presentation currency
(16,314)
(6,770)
Cash and cash equivalents at 30 September 
42,315 
157,605 
[1]The "Donetska" and "Volnovahska" laying farms in the Donetsk region and the "Bogoduhivska" laying farm in the Kharkiv region

This information is provided by RNS
The company news service from the London Stock Exchange
  END
QRTFEAEEWFISESF